RAC 2.60% $1.58 race oncology ltd

ASH2023 - Sheba 2.0, page-129

  1. 17,654 Posts.
    lightbulb Created with Sketch. 434
    As you have referred to a buy out analogy can you tell us , in your experience, at what stage of development could RAC be a realistic target ?

    Are there examples out there of very early buyouts in this sector ?

    Bisantrene seems to be a very promising drug .

    Im perhaps trying to work out the “safest” entry point to the stock
    I am very aware the returns can be better the earlier you enter , am also aware it takes many trials , money(raisings) etc to develop .
    ( an example is the recent PAR thread )
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.